Though the introduction of CAR-T treatments in CLL is relatively recent due to complications of CLL, compared to traditional stem-cell transplants with chemo- and radiotherapy, CD19 CAR-T treatments showed some curative effects with limited T cell expansion and proliferation due to immunodeficiency in patients (Turtle et al., 2016). Here, CD19 is linked to B-cell chronic lymphocytic leukemia.